Characterization and Optimization of Streptomyces albidoflavus MD102 as a heterologous expression chassis

This study characterizes *Streptomyces albidoflavus* MD102 as a highly tractable, fast-growing microbial chassis and optimizes it via CRISPR/Cas9-mediated genome reduction and strategic gene insertions to enhance its capacity for the heterologous production of diverse secondary metabolites.

The Gist

Imagine you are a master chef trying to create a new, complex dish (a valuable medicine or chemical) using a specific type of kitchen (a bacterium). For years, scientists have been trying to find the perfect "kitchen" to cook these recipes in. This paper introduces a new, upgraded kitchen called Streptomyces albidoflavus MD102.

Here is the story of how the scientists found it, upgraded it, and why it's a game-changer, explained simply:

1. The Search for the Perfect Kitchen

In the world of bacteria, Streptomyces are like tiny chemical factories. They naturally produce thousands of different compounds, many of which could become life-saving drugs. However, in their natural state, these factories are messy. They have their own "recipes" (genes) running in the background that create clutter, making it hard to see or isolate the new, special dish you are trying to make.

Scientists have used a famous kitchen called J1074 for a long time. It's fast, reliable, and easy to work with. But, they wanted a new option that was just as good but had some unique superpowers.

2. Finding the New Star (MD102)

The researchers went digging in the mud of a wetland in Singapore (Sungei Buloh) and found a new bacterium, MD102.

• The Cousin: When they looked at its DNA, they realized MD102 is basically a cousin of the famous J1074. It's fast-growing and easy to handle.
• The Superpower: Unlike J1074, MD102 has a secret weapon in its genetic code: it has the tools to break down aromatic compounds (think of these as sticky, oily pollutants like those found in oil spills or heavy traffic fumes).
  • The Analogy: If J1074 is a standard kitchen, MD102 is a kitchen equipped with a special industrial filter that can turn toxic smoke into ingredients. This means MD102 might be able to turn pollution into valuable medicines.

3. The "Spring Cleaning" (Genome Editing)

Even though MD102 was promising, it was still too "cluttered." It was making its own random chemicals that got in the way of the new recipes scientists wanted to test.

The scientists used a tool called CRISPR/Cas9 (think of this as "molecular scissors") to perform a massive spring cleaning:

• Deleting the Noise: They cut out the genes responsible for the bacteria's own messy chemical production. This made the "kitchen" cleaner, so when they added a new recipe, they wouldn't get confused by old leftovers.
• Adding Upgrades: They didn't just delete; they also installed new appliances:
  • The "Universal Translator" (bldA gene): Some recipes use a rare language (a specific genetic code) that the bacteria usually ignores. They added a translator so the bacteria could finally read and cook these complex recipes.
  • The "Fuel Pump" (gpps gene): They added a pump to produce more raw fuel (GPP) needed to make a specific type of chemical called terpenes (found in essential oils and many drugs).
  • The "Extra Door" (attB site): They added a second door to the kitchen so they could hang multiple new recipes on the wall at the same time without them bumping into each other.

4. Putting It to the Test

After the upgrades, the scientists tested the new MD102 kitchen:

• The Red Paint Test: They gave it a simple recipe to make a red pigment. It worked perfectly, turning the culture red.
• The Complex Recipe Test: They tried to make a complex, hidden chemical (a diterpenoid). While the bacteria successfully read the instructions, it struggled to finish the final step of the assembly line.
  • The Lesson: This showed that while the kitchen is ready, sometimes the specific tools (proteins) needed for the final step are missing or don't work well in this new environment. It's a "work in progress," but the foundation is solid.

5. Why This Matters

This paper is like announcing a new, high-tech kitchen model for the scientific community.

• It's Fast: It grows quickly, saving time.
• It's Clean: Scientists can delete its own noise to see their new creations clearly.
• It's Versatile: It can potentially turn environmental pollutants into valuable products.
• It's Compatible: It works with all the standard tools scientists already use.

In a nutshell: The scientists found a new bacterial "kitchen," gave it a massive renovation to remove clutter and add super-tools, and proved it's ready to start cooking up new medicines and chemicals for us. It's a powerful new addition to the toolbox of synthetic biology.

Technical Summary

1. Problem Statement

The discovery of novel secondary metabolites (SMs) is often hindered by the "silent" or cryptic nature of Biosynthetic Gene Clusters (BGCs) in native actinomycete strains, which remain dormant under standard laboratory conditions. While heterologous expression in a genetically tractable host is a proven strategy to activate these pathways, the pursuit of a single "universal" Streptomyces chassis has proven elusive. Existing chassis strains (e.g., S. coelicolor, S. lividans, S. albus) have limitations regarding growth rates, genetic manipulation efficiency, or background metabolite interference. There is a critical need for a suite of optimized chassis strains that offer rapid growth, high genetic tractability, and a "clean" metabolic background to facilitate the discovery and production of diverse SMs.

2. Methodology

The study employed a multi-faceted approach combining genomics, metabolic engineering, and synthetic biology:

• Isolation and Taxonomic Classification:
  • Strain MD102 was isolated from sediment in the Sungei Buloh Wetland Reserve, Singapore.
  • Genomic Sequencing: A hybrid approach using PacBio (long-read) and Illumina (short-read) sequencing was used to assemble the genome.
  • Phylogenetics: Genome BLAST Distance Phylogeny (GBDP) and OrthoANIu analysis were used to classify the strain, comparing it against S. albidoflavus J1074 and other model strains.
• Genomic Characterization:
  • Annotation was performed using RAST and antiSMASH to identify Open Reading Frames (ORFs), tRNA/rRNA operons, and Biosynthetic Gene Clusters (BGCs).
  • Comparative genomics (OrthoVenn3) identified unique genes, specifically those involved in aromatic compound degradation.
• Genome Engineering (CRISPR/Cas9):
  • The authors utilized a CRISPR/Cas9 system to perform targeted deletions of constitutively active endogenous BGCs (alteramides, paulomycin, candicidin, antimycins) to reduce chromatographic background noise.
  • Strain Optimization: Exogenous genes were inserted into the chromosome:
    • bldA: A global regulator (tRNA$^{Leu}$) to overcome rare codon limitations in SM expression.
    • gpps: Geranyl diphosphate synthase to boost the supply of terpenoid precursors.
    • $\Phi$BT1-attB: An additional phage attachment site to allow for multi-site integration of large BGCs.
• Functional Validation:
  • Transformation: Tested natural competence via E. coli-Streptomyces conjugation using various vectors (pIJ101, pSET152, cosmid, BAC).
  • Promoter Screening: Evaluated constitutive promoters (KasOp, gapdhp, SF14p) using an EGFP reporter system.
  • Heterologous Expression:
    • Expressed the fur1 gene (Type III PKS) to produce the red pigment flaviolin.
    • Refactored a cryptic terpene BGC (BGC6) from S. tasikensis P46 to test diterpenoid production.

3. Key Contributions

• Discovery of a New Chassis: Identification and characterization of Streptomyces albidoflavus MD102, a strain phylogenetically close to the widely used S. albidoflavus J1074 but with distinct advantages.
• Creation of an Optimized Mutant (MD102SL01): Development of a "clean" chassis strain via CRISPR/Cas9 that features:
  • Deletion of four major endogenous BGCs (reducing background metabolites).
  • Deletion of ~446 kb of genomic material (including terminal regions), resulting in a smaller, more streamlined genome.
  • Integration of bldA and gpps to enhance translation efficiency and precursor supply.
  • Addition of a second phage attachment site ($\Phi$BT1-attB) for versatile genetic integration.
• Unique Metabolic Potential: Identification of unique genes in MD102 (absent in J1074) responsible for aromatic compound degradation (e.g., biphenyl dioxygenases), suggesting potential for converting petrogenic polycyclic aromatic hydrocarbons (PAHs) into valuable metabolites.

4. Results

• Genomic Features:
  • MD102 has a genome size of ~7.05 Mb with 73.3% GC content, containing 7 rRNA operons (associated with rapid growth).
  • It shares 98.81% OrthoANIu identity with S. albidoflavus J1074, confirming close phylogenetic relationship.
  • Unlike J1074, MD102 possesses a Type I restriction modification system (R subunit) but lacks the SalI restriction system, facilitating transformation.
• Growth and Transformation:
  • MD102 exhibits rapid growth and sporulation, outperforming S. coelicolor M1154 and S. lividans TK24.
  • It is naturally competent and susceptible to common antibiotics (apramycin, chloramphenicol, kanamycin).
  • Successful integration of vectors (pIJ101, pSET152, cosmid, BAC) was achieved, though PAC-based vectors failed.
• Metabolic Engineering Outcomes:
  • Background Reduction: HPLC analysis of the mutant strain (MD102SL01) confirmed the complete loss of endogenous metabolites (paulomycin, candicidin, antimycin), resulting in a significantly cleaner chromatographic profile.
  • Promoter Strength: The KasOp, gapdhp(EL), and gapdh(KR) promoters were identified as the strongest constitutive promoters for this chassis.
  • Heterologous Production:
    • Success: The chassis successfully produced the red pigment flaviolin from the fur1 gene, validating its ability to express Type III PKS pathways.
    • Partial Success/Failure: A refactored cryptic terpene BGC was integrated, but the target diterpenoid was not detected. RT-PCR showed expression of the synthase genes but a lack of cytochrome P450 mRNA, indicating a bottleneck in the expression of specific orthogonal genes or protein solubility.

5. Significance

This study establishes S. albidoflavus MD102 as a robust, next-generation microbial chassis for synthetic biology and natural product discovery.

• Complement to Existing Tools: It serves as a valuable alternative to S. albidoflavus J1074, offering similar genetic tractability but with a "cleaner" background due to the removal of competing BGCs and a smaller genome.
• Enhanced Capabilities: The engineered strain (MD102SL01) is pre-optimized for the production of terpenes (via gpps) and complex SMs (via bldA), addressing common bottlenecks in heterologous expression.
• Novel Bioprospecting Potential: The unique presence of aromatic degradation genes suggests MD102 could be engineered as a specialized chassis for the biotransformation of environmental pollutants (PAHs) into high-value secondary metabolites, a feature not present in standard chassis strains.
• Methodological Advance: The successful application of CRISPR/Cas9 for large-scale genomic deletions and multi-gene insertions in this strain demonstrates a scalable workflow for creating customized chassis strains.